Key facts
- Schonfeld Strategic Advisors LLC filed SCHEDULE 13G/A for Skye Bioscience, Inc. Common Stock, par value $0.001 per share (SKYE).
- Disclosed ownership: 3.6%.
- Date of event: 30 Jun 2025.
Schonfeld Strategic Advisors LLC - 30 Jun 2025 SCHEDULE 13G/A Report for Skye Bioscience, Inc. Common Stock, par value $0.001 per share (SKYE)
- Filing Manager
- Schonfeld Strategic Advisors LLC
- Reporting Manager
- Schonfeld Strategic Advisors LLC
- Symbol
- SKYE
- Shares outstanding
- 30,998,306 shares
- Disclosed Ownership
- 1,115,939 shares
- Ownership
- 3.6%
- Form type
- SCHEDULE 13G/A
- Filing time
- 14 Aug 2025, 16:31:23 UTC
- Date of event
- 30 Jun 2025
- Previous filing
- 15 May 2025
- SEC
- View on sec.gov
Key filing fact
Schonfeld Strategic Advisors LLC disclosed 3.6% ownership in Skye Bioscience, Inc. Common Stock, par value $0.001 per share (SKYE) on 30 Jun 2025.
Change
- Previous schedule filing date: 15 May 2025.
- Current filing was accepted on 14 Aug 2025, 16:31.
Research use
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting persons
Reporting managers (1)
Names, ownership, voting power, signatures, titles, and CIKs as disclosed in this Schedule 13D/G filing.
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Schonfeld Strategic Advisors LLC | 3.6% | 1,115,939 | 1,115,939 | 0 | /s/ Hung Luc | Hung Luc, Chief Compliance Officer |
CIK / CUSIP context first